Equibles does not estimate personal net worth.
Get an email with a short summary when TherapeuticsMD, Inc. publishes a filing, an earnings call transcript or a press release.
Get TXMD alertsJoseph Ziegler is recorded as CFO at TherapeuticsMD, Inc. (TXMD) since August 17, 2023. TherapeuticsMD, Inc. reported in an 8-K filed August 18, 2023 that Joseph Ziegler was appointed Principal Financial and Accounting Officer, effective August 17, 2023. The proxy statement of TherapeuticsMD, Inc. reports total compensation of $82,900 for Joseph Ziegler in fiscal 2023, including a base salary of $52,900. TherapeuticsMD, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at TherapeuticsMD, Inc. includes Brian Bernick (CEO), Mark Glickman (CEO), Marlan D. Walker (CEO and General Counsel) and 7 others.
“Mr. Ziegler succeeded Mr. Donegan as Principal Financial and Accounting Officer as of the effective date of Mr. Donegan's resignation.”
2023-08-17–present
Proxy statement
Start not stated–present
Last confirmed November 3, 2025
TXMD
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
2023-08-17–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | TherapeuticsMD, Inc. (TXMD) | Principal Financial and Accounting Officer | $52,900 | $82,900 |
